RE: Customers' investment29 Aug 2023 22:57
i seem to recall that there was a degree of finacial support from certain customers when they converted the hotel. believe it was to expediate their own study slot, due to the capacity being already full and contracts were backing up, so to speak.
guessing that his could be for similar reasons. maybe not preferencial, as such, just moving things along.
whilst looking through back rns's on the old oo board it was interesting to reacquaint myself with mo's bio from when he joined the board as a non-executive director.
"mo is a business leader and customer-focused cro executive with over 25 years of global clinical research experience across clinical operations, project management, business development and executive management functions. he previously worked at pharm-olam international, a global cro, from 2000-2019 across a variety of senior positions including executive vice president of clinical development and global director of clinical operations. mo was a key leader in driving the expansion and growth of the company from a small niche european cro to a global player with offices across all continents. laterally, he led global business development at pharm-olam resulting in significant growth and a successful sale in 2017, delivering substantial returns to its shareholders. prior to this he worked at innovex and *****iles cro (iqvia)."
stand out bit and what seems to be mo's m.o., "... driving the expansion and growth of the company ..."
just putting this out there, as a shareholder, i quite like "substantial returns". just sayin' :)
gla.
Sign In
Follow the stocks
